We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

527 hedge funds and large institutions have $16B invested in Abiomed Inc in 2018 Q2 according to their latest regulatory filings, with 153 funds opening new positions, 157 increasing their positions, 171 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

428% more first-time investments, than exits

New positions opened: 153 | Existing positions closed: 29

40% more funds holding in top 10

Funds holding in top 10: 15 → 21 (+6)

40% more capital invested

Capital invested by funds: $11.5B → $16B (+$4.55B)

30% more funds holding

Funds holding: 405 → 527 (+122)

8% less repeat investments, than reductions

Existing positions increased: 157 | Existing positions reduced: 171

21% less call options, than puts

Call options by funds: $167M | Put options by funds: $212M

Holders
527
Holders Change
+122
Holders Change %
+30.12%
% of All Funds
12.07%
Holding in Top 10
21
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+40%
% of All Funds
0.48%
New
153
Increased
157
Reduced
171
Closed
29
Calls
$167M
Puts
$212M
Net Calls
-$45.4M
Net Calls Change
-$39.3M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$297M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$210M
3
State Street
State Street
Massachusetts
+$158M
4
Renaissance Technologies
Renaissance Technologies
New York
+$146M
5
Two Sigma Investments
Two Sigma Investments
New York
+$138M

Top Sellers

1
BlackRock
BlackRock
New York
-$315M
2
Winslow Capital Management
Winslow Capital Management
Minnesota
-$284M
3
PAI
Palo Alto Investors
California
-$165M
4
William Blair Investment Management
William Blair Investment Management
Illinois
-$154M
5
American Century Companies
American Century Companies
Missouri
-$136M
Name Holding Trade Value Shares
Change 		Change in
Stake
EP
251
Eversept Partners
New York
$2.29M -$543K -1,500 -21%
Nomura Asset Management
252
Nomura Asset Management
Japan
$2.29M +$2.02M +5,586 New
TAM
253
Tyers Asset Management
Texas
$2.25M +$249K +688 +14%
DF
254
Donoghue Forlines
Massachusetts
$2.2M +$1.95M +5,388 New
SSP
255
Sapphire Star Partners
Washington
$2.15M +$90.6K +250 +5%
S
256
SignatureFD
Georgia
$2.12M +$1.6M +4,410 +580%
AG
257
Advisor Group
Arizona
$2.02M -$536K -1,480 -23%
Wellington Management Group
258
Wellington Management Group
Massachusetts
$1.99M -$571K -1,575 -24%
NB
259
Norinchukin Bank
Japan
$1.96M +$1.73M +4,787 New
PCM
260
Portolan Capital Management
Massachusetts
$1.92M -$905K -2,499 -35%
CAM
261
ClariVest Asset Management
California
$1.92M +$1.7M +4,700 New
HH
262
Hilltop Holdings
Texas
$1.91M +$35.1K +97 +2%
Bank of Nova Scotia
263
Bank of Nova Scotia
Ontario, Canada
$1.91M +$1.69M +4,671 New
PL
264
Plancorp LLC
Missouri
$1.88M – – –
SB
265
Suntrust Banks
Georgia
$1.85M +$182K +503 +12%
Connor, Clark & Lunn Investment Management (CC&L)
266
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.81M +$1.6M +4,425 New
COPPSERS
267
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.81M -$2.51M -6,918 -61%
DCM
268
Dupont Capital Management
Delaware
$1.81M +$1.4M +3,862 +698%
SAM
269
Securian Asset Management
Minnesota
$1.8M -$280K -773 -15%
KA
270
Kaizen Advisory
Illinois
$1.75M +$1.17M +3,231 +308%
AWP
271
Ascent Wealth Partners
New York
$1.74M -$92.7K -256 -6%
EAMA
272
EFG Asset Management (Americas)
Florida
$1.7M +$718K +1,982 +91%
WIC
273
Whitegate Investment Counselors
New Hampshire
$1.69M – – –
DTL
274
Dynamic Technology Lab
Singapore
$1.66M +$1.47M +4,060 New
EF
275
Empowered Funds
Pennsylvania
$1.66M -$189K -522 -12%
9 10
11
12 13

ABMD Hedge Fund Activity: Q2 2018 in Review

527 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2018, worth a combined $16B — up 40% from $11.5B a quarter earlier.

Buyers outnumbered sellers: 153 funds opened new ABMD positions and 29 closed out — a net gain of 124 holders — while 157 added to existing stakes and 171 trimmed.

The largest buyer was Vanguard Group, adding an estimated $297M. The largest seller was BlackRock, cutting an estimated $315M.

  • 527 institutional investors held Abiomed Inc (ABMD) as of Q2 2018, up from 405 in Q1 2018.
  • Funds reported $16B of Abiomed Inc stock for Q2 2018, up 40% quarter-over-quarter.
  • 153 funds opened new Abiomed Inc positions in Q2 2018 and 29 closed out, a net change of +124 holders.
  • The largest Abiomed Inc buyer in Q2 2018 was Vanguard Group, an estimated $297M added.
  • The largest Abiomed Inc seller in Q2 2018 was BlackRock, an estimated $315M sold.

Based on aggregated 13F filings for Q2 2018.